AEterna Zentaris - Stock Price History | AEZS

Historical daily share price chart and data for AEterna Zentaris since 2020 adjusted for splits. The latest closing stock price for AEterna Zentaris as of April 03, 2020 is 0.47.
  • The all-time high AEterna Zentaris stock closing price was 6826.63 on June 16, 2000.
  • The AEterna Zentaris 52-week high stock price is 5.49, which is 1068.1% above the current share price.
  • The AEterna Zentaris 52-week low stock price is 0.40, which is 14.9% below the current share price.
  • The average AEterna Zentaris stock price for the last 52 weeks is 1.80.
AEterna Zentaris Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.6081 3.0300 5.4300 0.7716 0.9100 -69.05%
2018 2.0058 2.3700 3.8700 1.1900 2.9400 24.58%
2017 2.1091 3.5000 3.6500 0.8388 2.3600 -34.44%
2016 3.5338 4.4000 4.9400 2.6700 3.6000 -19.64%
2015 29.7027 60.0100 84.2000 4.0000 4.4800 -92.53%
2014 113.0131 144.0000 150.0000 52.0000 60.0000 -56.52%
2013 181.3772 253.0000 323.0000 103.0000 138.0000 -42.02%
2012 478.8337 947.8104 1289.7421 187.0000 238.0000 -74.24%
2011 1117.9890 1043.7912 1547.6905 857.8284 923.8152 -10.47%
2010 711.7805 493.1014 1253.7493 473.9052 1031.7936 113.16%
2009 718.8250 287.9424 1697.6605 275.9448 484.0432 64.67%
2008 633.9757 929.8140 1079.7840 239.9520 293.9412 -68.18%
2007 1816.5400 2369.5261 2615.4769 875.8848 923.8152 -61.98%
2006 3501.0021 3119.3761 4439.1122 2429.5141 2429.5141 -20.59%
2005 3016.3917 3785.2430 3785.2430 2489.5021 3059.3881 -18.53%
2004 3482.4702 2045.5909 4889.0222 1985.6029 3755.2490 85.21%
2003 2468.8872 2243.5513 4241.1518 1469.7061 2027.5945 -9.38%
2002 2553.6321 3455.3089 4031.1938 1157.7684 2237.5525 -37.63%
2001 3589.6530 4427.1146 5098.9802 2381.5237 3587.2825 -18.97%
2000 5153.0430 6376.7247 6826.6347 3185.3629 4427.1146 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.011B $0.001B
AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead oncology program is a Phase 2 trial in endometrial and ovarian cancer with AEZS-108, a targeted cytotoxic peptide conjugate. Other lead compounds include ozarelix for BPH and prostate cancer as well as perifosine for multiple cancers.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.152B 13.85
Gilead Sciences (GILD) United States $98.468B 12.74
CSL (CSLLY) Australia $82.413B 0.00
Vertex Pharmaceuticals (VRTX) United States $61.786B 56.07
Regeneron Pharmaceuticals (REGN) United States $54.274B 22.99
Biogen (BIIB) United States $52.308B 8.93
Illumina (ILMN) United States $38.735B 40.05
Seattle Genetics (SGEN) United States $20.070B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.938B 9.25
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.036B 36.55
BioMarin Pharmaceutical (BMRN) United States $15.152B 647.77
Genmab (GMAB) Denmark $13.158B 10.21
Galapagos (GLPG) Belgium $12.305B 26.87
Alnylam Pharmaceuticals (ALNY) United States $11.965B 0.00
BioNTech SE (BNTX) Germany $11.935B 0.00
Genmab (GNMSF) Denmark $11.706B 37.65
Moderna (MRNA) United States $11.462B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.922B 51.05
QIAGEN (QGEN) Netherlands $9.172B 27.97
BeiGene (BGNE) Cayman Islands $9.117B 0.00
Exact Sciences (EXAS) United States $8.249B 0.00
Sarepta Therapeutics (SRPT) United States $7.281B 0.00
Bio-Techne Corp (TECH) United States $7.148B 48.92
ACADIA Pharmaceuticals (ACAD) United States $6.332B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.965B 15.76
Guardant Health (GH) United States $5.709B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.644B 0.00
Ascendis Pharma (ASND) Denmark $5.347B 0.00
Repligen (RGEN) United States $5.115B 93.53
Exelixis (EXEL) United States $5.045B 16.20
Acceleron Pharma (XLRN) United States $4.309B 0.00
Reata Pharmaceuticals (RETA) United States $4.282B 0.00
China Biologic Products (CBPO) China $3.976B 23.60
Adaptive Biotechnologies (ADPT) United States $3.249B 0.00
Blueprint Medicines (BPMC) United States $3.225B 0.00
Global Blood Therapeutics (GBT) United States $3.203B 0.00
Mirati Therapeutics (MRTX) United States $3.193B 0.00
Vir Biotechnology (VIR) United States $3.184B 0.00
MorphoSys AG (MOR) Germany $3.168B 0.00
Emergent Biosolutions (EBS) United States $2.998B 20.82
Zai Lab (ZLAB) China $2.995B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.837B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.796B 0.00
NeoGenomics (NEO) United States $2.538B 110.04
Amicus Therapeutics (FOLD) United States $2.400B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.396B 40.60
Bluebird Bio (BLUE) United States $2.329B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.90
Halozyme Therapeutics (HALO) United States $2.244B 0.00
Alkermes (ALKS) Ireland $2.228B 176.50
MyoKardia (MYOK) United States $2.160B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.062B 0.00
UniQure (QURE) Netherlands $2.016B 0.00
Immunomedics (IMMU) United States $2.011B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.930B 0.00
Denali Therapeutics (DNLI) United States $1.813B 0.00
Fate Therapeutics (FATE) United States $1.742B 0.00
Alector (ALEC) United States $1.720B 0.00
Amarin (AMRN) Ireland $1.707B 0.00
Principia Biopharma (PRNB) United States $1.610B 0.00
Viela Bio (VIE) United States $1.572B 0.00
Arvinas (ARVN) United States $1.553B 0.00
Eidos Therapeutics (EIDX) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.533B 0.00
Akcea Therapeutics (AKCA) United States $1.471B 31.63
Insmed (INSM) United States $1.428B 0.00
Epizyme (EPZM) United States $1.401B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.320B 0.00
Ligand Pharmaceuticals (LGND) United States $1.209B 37.55
Inovio Pharmaceuticals (INO) United States $1.128B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Zealand Pharma (ZEAL) Denmark $1.106B 0.00
Editas Medicine (EDIT) United States $1.073B 0.00
Twist Bioscience (TWST) United States $1.065B 0.00
REGENXBIO (RGNX) United States $1.031B 0.00
Coherus BioSciences (CHRS) United States $1.019B 12.13
NextCure (NXTC) United States $0.963B 0.00
Myriad Genetics (MYGN) United States $0.912B 16.10
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.844B 0.00
I-Mab (IMAB) China $0.827B 0.00
Beam Therapeutics (BEAM) United States $0.827B 0.00
Novavax (NVAX) United States $0.804B 0.00
Intra-Cellular Therapies (ITCI) United States $0.798B 0.00
Revance Therapeutics (RVNC) United States $0.781B 0.00
Sangamo Therapeutics (SGMO) United States $0.752B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.722B 0.00
Adverum Biotechnologies (ADVM) United States $0.713B 0.00
Cytokineticsorporated (CYTK) United States $0.711B 0.00
Arcus Biosciences (RCUS) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.662B 0.00
Retrophin (RTRX) United States $0.638B 0.00
GENFIT S.A (GNFT) France $0.620B 0.00
Cara Therapeutics (CARA) United States $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.591B 0.00
Intellia Therapeutics (NTLA) United States $0.586B 0.00
Athenex (ATNX) United States $0.580B 0.00
Codexis (CDXS) United States $0.577B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.551B 4.84
Compugen (CGEN) Israel $0.510B 0.00
AC Immune SA (ACIU) Switzerland $0.507B 12.95
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.487B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
Intrexon (PGEN) United States $0.480B 0.00
Athersys (ATHX) United States $0.473B 0.00
Frequency Therapeutics (FREQ) United States $0.471B 0.00
Castle Biosciences (CSTL) United States $0.470B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.463B 8.35
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Sorrento Therapeutics (SRNE) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.448B 0.00
MeiraGTx Holdings (MGTX) United States $0.436B 0.00
Scholar Rock Holding (SRRK) United States $0.430B 0.00
Heska (HSKA) United States $0.425B 0.00
Morphic Holding (MORF) United States $0.415B 0.00
Prothena (PRTA) Ireland $0.413B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
Anika Therapeutics (ANIK) United States $0.394B 13.58
Verastem (VSTM) United States $0.391B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.388B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
UROGEN PHARMA (URGN) United States $0.384B 0.00
Agenus (AGEN) United States $0.383B 0.00
Vericel (VCEL) United States $0.382B 56.67
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
BioDelivery Sciences (BDSI) United States $0.365B 42.11
Cellectis S.A (CLLS) France $0.354B 0.00
MiMedx (MDXG) United States $0.354B 0.00
Cue Biopharma (CUE) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.342B 0.00
Kala Pharmaceuticals (KALA) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.329B 9.85
Merus (MRUS) Netherlands $0.305B 0.00
Cellular Biomedicine (CBMG) United States $0.300B 0.00
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Dynavax Technologies (DVAX) United States $0.273B 0.00
Puma Biotechnology (PBYI) United States $0.273B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.267B 0.00
Syros Pharmaceuticals (SYRS) United States $0.265B 0.00
NantKwest (NK) United States $0.256B 0.00
Kamada (KMDA) Israel $0.255B 10.59
Avid Bioservices (CDMO) United States $0.245B 0.00
Precision BioSciences (DTIL) United States $0.240B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.238B 0.00
Albireo Pharma (ALBO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
Stemline Therapeutics (STML) United States $0.225B 0.00
Sutro Biopharma (STRO) United States $0.217B 0.00
Seres Therapeutics (MCRB) United States $0.216B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.216B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.210B 0.00
Geron (GERN) United States $0.210B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
MannKind (MNKD) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Alcobra (ARCT) United States $0.197B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.188B 1.69
XOMA (XOMA) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.180B 0.00
Starpharma Holdings (SPHRY) Australia $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
Protagonist Therapeutics (PTGX) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.158B 0.00
Prometic Life Sciences (LMNL) Canada $0.156B 0.00
IVERIC Bio (ISEE) United States $0.152B 0.00
OSMOTICA PHARM (OSMT) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Fortress Biotech (FBIO) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Aytu Bioscience (AYTU) United States $0.147B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Kindred Biosciences (KIN) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Cerecor (CERC) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.123B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.117B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.115B 0.00
VTv Therapeutics (VTVT) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Strongbridge Biopharma (SBBP) United States $0.094B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Aptinyx (APTX) United States $0.091B 0.00
OvaScience (MLND) United States $0.089B 0.00
PHASEBIO PHARMA (PHAS) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Five Prime Therapeutics (FPRX) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.078B 0.00
Orgenesis (ORGS) United States $0.073B 4.27
Clearside Biomedical (CLSD) United States $0.071B 0.00
Cyclerion Therapeutics (CYCN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.063B 0.00
Arbutus Biopharma (ABUS) Canada $0.063B 0.00
Eton Pharmaceuticals (ETON) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.057B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Synlogic (SYBX) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Trevena (TRVN) United States $0.046B 0.00
Catalyst Biosciences (CBIO) United States $0.045B 0.00
Stealth BioTherapeutics (MITO) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Prima BioMed (IMMP) Australia $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Evogene (EVGN) Israel $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Aptevo Therapeutics (APVO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00